Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma
- 31 May 1999
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 81 (5) , 761-766
- https://doi.org/10.1002/(sici)1097-0215(19990531)81:5<761::aid-ijc16>3.0.co;2-1
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?The Lancet, 1998
- Inhibition of stromal matrix metalloproteases: Effects on breast-tumor promotion by fibroblastsInternational Journal of Cancer, 1998
- Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3Cell, 1996
- Inhibition by Interleukin-4 of Stromelysin Expression in Human Skin Fibroblasts: Role of PKCExperimental Cell Research, 1996
- Matrix metalloproteinase inhibition: A review of anti-tumour activityAnnals of Oncology, 1995
- ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarctionThe Lancet, 1995
- Proteolytic remodeling of extracellular matrixCurrent Opinion in Cell Biology, 1995
- Inhibition of the metastatic spread and growth of B16‐BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitorInternational Journal of Cancer, 1994
- Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells.Proceedings of the National Academy of Sciences, 1994
- Cancer metastasis and angiogenesis: An imbalance of positive and negative regulationCell, 1991